Loading...
XHKG
0574
Market cap8mUSD
Dec 05, Last price  
0.04HKD
1D
-2.22%
1Q
-8.33%
Jan 2017
-91.37%
IPO
-98.00%
Name

Pa Shun International Holdings Ltd

Chart & Performance

D1W1MN
XHKG:0574 chart
P/E
P/S
0.68
EPS
Div Yield, %
Shrs. gr., 5y
0.37%
Rev. gr., 5y
-36.61%
Revenues
87m
-33.13%
712,111,000794,349,000847,193,000867,963,000860,574,000869,891,000821,142,000845,448,000474,835,00086,426,00071,784,000129,430,00086,554,000
Net income
-15m
L
9,409,00063,070,00045,944,00088,257,0007,675,00010,177,000-59,409,000-193,399,000-419,189,000-54,383,000-43,379,0002,350,000-15,313,000
CFO
-2m
L-95.20%
-42,242,00092,225,00048,664,000-35,758,000-777,000-95,981,00017,867,000-58,454,000-6,509,000-21,895,000-2,321,000-34,933,000-1,676,000
Dividend
Jun 06, 20160.03 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Pa Shun International Holdings Limited, an investment holding company, engages in the pharmaceutical distribution activities in the People's Republic of China. It operates through three segments: Pharmaceutical Distribution, Self-Operated Retail Pharmacies, and Pharmaceutical Manufacturing. The Pharmaceutical Distribution segment sells pharmaceutical products to wholesalers, franchise retail pharmacy chain stores, and hospitals and other medical institutions in rural areas. The Self-Operated Retail Pharmacies segment engages in the sale of pharmaceutical and healthcare products, cosmetic products, and daily necessities in self-operated retail pharmacies. The Pharmaceutical Manufacturing segment sells pharmaceutical products manufactured by the company. The company was formerly known as Pa Shun Pharmaceutical International Holdings Limited and changed its name to Pa Shun International Holdings Limited in June 2017. The company was incorporated in 2011 and is based in San Po Kong, Hong Kong. Pa Shun International Holdings Limited is a subsidiary of Praise Treasure Limited.
IPO date
Jun 19, 2015
Employees
95
Domiciled in
HK
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT